The cardiovascular care of thousands of Missouri patients is suddenly up in the air. The heart of the issue is a practice's alleged interest in opening up a new private equity-backed clinic.
On Tuesday, a judge formally rejected a motion by the company to have the case dismissed. Carelon Behavioral Health, a subsidiary of Elevance, is accused of publishing an inaccurate directory of providers for those seeking mental health services.
The Federal Trade Commission is suing Illumina, a gene sequencing firm, in an effort to stop its proposed $7.1 billion acquisition of life sciences firm Grail.
The FDA has given the all-clear to AI software that measures nodules in the lungs, a tedious but important task for radiologists monitoring changes in these growths over time.
An AI system for diagnosing prostate cancer on biopsy slides has achieved 98%-plus performance in sensitivity, positive predictive value, specificity and negative predictive value.
Growing imaging workloads and clear patient benefits should encourage rads to see this as an opportunity rather than a turf threat, two experts argued in a new editorial.
Two healthcare heavyweights are combining forces to form a technology center they hope will, over the next 10 years, “fundamentally advance the pace” of discovery in medical science and healthcare innovation.
In healthcare, it is likely that an increased demand for telehealth will remain, meaning providers will need to continue ramping up their capabilities and personalizing this care.
